Recombinant FGFR2 (Aprutumab Biosimilar) antibody

Catalog No. ABIN7675664

The Human Monoclonal anti-FGFR2 (Aprutumab Biosimilar) antibody (ABIN7675664) specifically detects FGFR2 (Aprutumab Biosimilar) in BLI, ELISA, FACS, Func and SPR. The antibody is reactive with Human samples.

Quick Overview for Recombinant FGFR2 (Aprutumab Biosimilar) antibody (ABIN7675664)

Target: FGFR2 (Aprutumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This FGFR2 (Aprutumab Biosimilar) antibody is un-conjugated

Application: Bio-Layer Interferometry (BLI), ELISA, Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-FGFR2 (Aprutumab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-FGFR2 / CD332 Reference Antibody (aprutumab)

Characteristics: Anti-FGFR2 / CD332 Reference Antibody (aprutumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hulambda. It has a predicted MW of 78.2 kDa.

Purity: >95 %

Isotype: IgG1

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for FGFR2 (Aprutumab Biosimilar)

Target: FGFR2 (Aprutumab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 78.2 kDa

UniProt: P21802